Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Condensed Consolidated Statements of Operations [Abstract]    
Revenue $ 53,451 $ 101,825
Cost of Revenue 23,057 54,780
Gross Profit 30,394 47,045
Operating Expenses:    
Selling expenses 8,262 5,223
Administrative expenses 114,469 1,279,160
Research and development    3,000
Depreciation    1,548
Total Operating Expenses 122,731 1,288,931
Loss from operations (92,337) (1,241,886)
Other Income (Expenses)    
Loss on derivative financial instrument   (104,854)
Gain on debt conversion, net    367,046
Loss on share exchange    (919,642)
Interest and other expenses (18,715) (58,448)
Total Other Income (Expense) (18,715) (715,898)
Net loss $ (111,052) $ (1,957,784)
Loss per common share - basic and diluted $ (0.0001) $ (1.58)
Weighted average of shares outstanding: Basic and diluted 2,080,095,492 1,236,472